These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9473407)
1. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Zucker S; Mirza H; Conner CE; Lorenz AF; Drews MH; Bahou WF; Jesty J Int J Cancer; 1998 Mar; 75(5):780-6. PubMed ID: 9495249 [TBL] [Abstract][Full Text] [Related]
3. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408 [TBL] [Abstract][Full Text] [Related]
4. Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium. Basilico N; Magnetto C; D'Alessandro S; Panariti A; Rivolta I; Genova T; Khadjavi A; Gulino GR; Argenziano M; Soster M; Cavalli R; Giribaldi G; Guiot C; Prato M Toxicol Appl Pharmacol; 2015 Nov; 288(3):330-8. PubMed ID: 26276311 [TBL] [Abstract][Full Text] [Related]
5. The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. Tamaki M; McDonald W; Del Maestro RF J Neurooncol; 1998 Sep; 39(3):205-16. PubMed ID: 9821106 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Enomoto H; Inoki I; Komiya K; Shiomi T; Ikeda E; Obata K; Matsumoto H; Toyama Y; Okada Y Am J Pathol; 2003 Jan; 162(1):171-81. PubMed ID: 12507900 [TBL] [Abstract][Full Text] [Related]
7. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594 [TBL] [Abstract][Full Text] [Related]
10. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope. Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A Neurosurgery; 2002 Mar; 50(3):578-86; discussion 586-8. PubMed ID: 11841727 [TBL] [Abstract][Full Text] [Related]
11. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Isaji M; Miyata H; Ajisawa Y; Takehana Y; Yoshimura N Br J Pharmacol; 1997 Nov; 122(6):1061-6. PubMed ID: 9401770 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Padgett LC; Lui GM; Werb Z; LaVail MM Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473 [TBL] [Abstract][Full Text] [Related]
13. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633 [TBL] [Abstract][Full Text] [Related]
15. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors. Jia MC; Schwartz MA; Sang QA Adv Exp Med Biol; 2000; 476():181-94. PubMed ID: 10949665 [TBL] [Abstract][Full Text] [Related]
16. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Ment LR; Stewart WB; Fronc R; Seashore C; Mahooti S; Scaramuzzino D; Madri JA Brain Res Dev Brain Res; 1997 May; 100(1):52-61. PubMed ID: 9174246 [TBL] [Abstract][Full Text] [Related]
19. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Ribatti D; Alessandri G; Vacca A; Iurlaro M; Ponzoni M Int J Cancer; 1998 Jul; 77(3):449-54. PubMed ID: 9663609 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]